AI
DXCM icon

Atom Investors’s DexCom DXCM Stock Holding History

Atom Investors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,106
Closed -$1.26M – 884
2026
Q1 		$1.26M Buy
+20,106
New +$1.4M 0.09% 319
2025
Q3 		– Sell
-63,582
Closed -$5.55M – 663
2025
Q2 		$5.55M Buy
+63,582
New +$4.98M 0.49% 42
2024
Q3 		– Sell
-10,138
Closed -$1.15M – 503
2024
Q2 		$1.15M Buy
10,138
+3,301
+48% +$417K 0.11% 229
2024
Q1 		$948K Buy
6,837
+2,205
+48% +$277K 0.12% 229
2023
Q4 		$575K Buy
+4,632
New +$473K 0.1% 257
2020
Q4 		– Sell
-10,744
Closed -$1.11M – 430
2020
Q3 		$1.11M Buy
+10,744
New +$1.12M 0.11% 180
2020
Q1 		– Sell
-5,912
Closed -$323K – 333
2019
Q4 		$323K Buy
5,912
+56
+1% +$2.66K 0.03% 195
2019
Q3 		$218K Sell
5,856
-1,780
-23% -$69.2K 0.01% 264
2019
Q2 		$286K Buy
+7,636
New +$240K 0.02% 348

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Atom Investors's DXCM Position: Q2 2026 in Review

Atom Investors sold out of DexCom (DXCM) in Q2 2026, closing a stake of 20,106 shares — an estimated $1.26M sold.

Atom Investors first reported a position in DXCM in Q2 2019 and held it in 9 quarters. The position peaked at $5.55M in Q2 2025. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Atom Investors reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
  • Atom Investors sold 20,106 DexCom shares in Q2 2026, an estimated $1.26M.
  • Atom Investors first reported a position in DexCom in Q2 2019 and held it in 9 quarters.
  • Atom Investors's DexCom position peaked at $5.55M in Q2 2025.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.